IRVINE, Calif., April 2, 2025 /PRNewswire/ — University Lab Partners (ULP) proudly announces the selection of nine cutting-edge MedTech companies for the inaugural cohort of the International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE). I-CREATE serves as the BARDA Accelerator Network’s Medical Devices and Diagnostics Hub and is executed in partnership with CIMIT and Science Exchange.
“We are thrilled to welcome this exceptional group of companies, representing diverse and groundbreaking innovations,” said Sandra J. Miller, Executive Director of University Lab Partners. “We look forward to supporting them, alongside our partners, as they advance their technologies to address critical health security challenges.”
The I-CREATE Accelerator provides non-dilutive funding and mentorship to address critical health security challenges.
About I-CREATE and the 2025 Cohort
I-CREATE is one of five strategic BARDA Accelerator Network Hubs (BAN 2.0), focused on empowering innovative startups to accelerate the development, scalability, and commercialization of medical devices and diagnostics globally. The program emphasizes advancing innovative technology to develop medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases
Three companies will each receive up to $200,000 in non-dilutive funding, customized mentorship to fit their needs, and consulting over six months to support the development, evaluation, or validation of their diagnostic or medical device solution.
Full story: University Lab Partners Welcomes Groundbreaking MedTech Companies to the I-CREATE Accelerator Program
